Galbraith Kenneth

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$1.5M
Insider Sells Quantity
3
Insider Sells Sum
$445,554.59

Insider Activity of Galbraith Kenneth

According to the SEC Form 4 filings, Galbraith Kenneth, being in a position of

  1. Chair & CEO at Zymeworks Inc.,
    оver the last 12 months, has bought 0 shares, and sold 23904 shares for $257,845,
    over all time since 2024-01-05, has bought 0 shares, and sold 23904 shares for $257,845.

The largest purchase of all time was on 2013-10-16 and amounted to 93750 shares of MacroGenics, Inc. for $1.5M.

The largest sale of all time was on 2024-01-05 and amounted to 18198 shares of Zymeworks Inc. for $193,849.

Biography of Galbraith Kenneth

No biography is available at this moment.

2024-01-08SaleZymeworks Inc.
ZYME
Chair & CEO
5,706
0.0079%
$11.22$63,996-7.63%
2024-01-05SaleZymeworks Inc.
ZYME
Chair & CEO
18,198
0.0262%
$10.65$193,849+0.95%
2020-09-09SaleMacroGenics, Inc.
MGNX
director
6,924
0.0127%
$27.11$187,710-8.85%
2013-10-16PurchaseMacroGenics, Inc.
MGNX
director
93,750
0.2246%
$16.00$1.5M-11.58%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.